In recent years, cannabis has been at the center of one of the most important developments in modern science, which has significantly advanced our understanding of health and disease.
I wanted to relay the experience I’m having with CBD aiding opiate withdrawal. I am a 72-year-old woman. A doctor put me on fentanyl patches about 10 years ago, after trying various painkillers for my intense fibromyalgia pain. They did not notify me how difficult, if not impossible, it would be to get off of them. I use the generic Mylan brand, which can be cut down without deleterious effects. Several times over the years I have attempted to taper down, but even cutting off the tiniest sliver of the patch resulted in intense withdrawal symptoms, so I gave up.
A pioneer neurologist, Dr. Ethan Russo, examines recent scientific data on migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes that may respond to cannabinoid therapies.
Our video series Cannabis Conversations interviews Dr. Ethan Russo on clinical endocannabinoid deficiency and ways to target the endocannabinoid system for therapeutic benefit.
Care By Design surveyed thousands of patients who had been using CBD-rich cannabis medicines for over 30 days. They asked patients what they were taking CBD-rich cannabis for, the ratio of CBD-to-THC they were using, and about its impact on pain, discomfort, energy, mood, and overall wellbeing.
Here’s what they learned: